1ST Biotherapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch 1ST Biotherapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects (NCT07126704) | 1ST Biotherapeutics, Inc. | 2025-11-01 |
| A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418 (NCT05995782) | 1ST Biotherapeutics, Inc. | 2023-12-20 |
| A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 (NCT05761223) | 1ST Biotherapeutics, Inc. | 2023-12-13 |
| Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects (NCT04165837) | 1ST Biotherapeutics, Inc. | 2019-10-14 |
Track 1ST Biotherapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.